Herrman H, Patel V, Kieling C, Berk M, Buchweitz C, Cuijpers P, et al. Time for united action on depression: a Lancet-World Psychiatric Association Commission. Lancet Lond Engl. 2022;399(10328):957–1022.
Quintanilla B, Zarate CA, Pillai A. Ketamine’s mechanism of action with an emphasis on neuroimmune regulation: can the complement system complement ketamine’s antidepressant effects? Mol Psychiatry. 2024;29(9):2849–58.
Article CAS PubMed Google Scholar
Solmi M, Fornaro M, Ostinelli EG, Zangani C, Croatto G, Monaco F, et al. Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects. World Psychiatry Off J World Psychiatr Assoc WPA. 2020;19(2):214–32.
Howes OD, Thase ME, Pillinger T. Treatment resistance in psychiatry: state of the art and new directions. Mol Psychiatry. 2022;27(1):58–72.
Imbrici P, Camerino DC, Tricarico D. Major channels involved in neuropsychiatric disorders and therapeutic perspectives. Front Genet. 2013;4:76.
Article PubMed PubMed Central Google Scholar
Moiseenkova-Bell V, Delemotte L, Minor DL. Ion channels: intersection of structure, function, and pharmacology. J Mol Biol. 2021;433(17):167102.
Article CAS PubMed Google Scholar
Krupp JJ. Role of ion channels in neurological disorders. CNS Neurol Disord Drug Targets. 2008;7(2):120–1.
Article CAS PubMed Google Scholar
Tian C, Zhu R, Zhu L, Qiu T, Cao Z, Kang T. Potassium channels: structures, diseases, and modulators. Chem Biol Drug Des. 2014;83(1):1–26.
Article CAS PubMed Google Scholar
French JA, Porter RJ, Perucca E, Brodie MJ, Rogawski MA, Pimstone S, et al. Efficacy and safety of XEN1101, a novel potassium channel opener, in adults with focal epilepsy: a phase 2b randomized clinical trial. JAMA Neurol. 2023;80(11):1145–54.
Article PubMed PubMed Central Google Scholar
Etcheberrigaray R, Ito E, Oka K, Tofel-Grehl B, Gibson GE, Alkon DL. Potassium channel dysfunction in fibroblasts identifies patients with Alzheimer disease. Proc Natl Acad Sci USA. 1993;90(17):8209–13.
Article CAS PubMed PubMed Central Google Scholar
Sun HS, Feng ZP. Neuroprotective role of ATP-sensitive potassium channels in cerebral ischemia. Acta Pharmacol Sin. 2013;34(1):24–32.
Catterall W, Epstein PN. Ion channels. Diabetologia. 1992;35(Suppl 2):S23-33.
Duman RS, Aghajanian GK. Synaptic dysfunction in depression: potential therapeutic targets. Science. 2012;338(6103):68–72.
Article CAS PubMed PubMed Central Google Scholar
Baert T, Vande Casteele T, Bouckaert F, Vandenbulcke M. Neural networks in late life depression. Tijdschr Voor Psychiatr. 2023;65(10):624–8.
Zhang B, Qi S, Liu S, Liu X, Wei X, Ming D. Altered spontaneous neural activity in the precuneus, middle and superior frontal gyri, and hippocampus in college students with subclinical depression. BMC Psychiatry. 2021;21(1):280.
Article CAS PubMed PubMed Central Google Scholar
Pongs O. Regulation of excitability by potassium channels. Results Probl Cell Differ. 2008;44:145–61.
Article CAS PubMed Google Scholar
Kuang Q, Purhonen P, Hebert H. Structure of potassium channels. Cell Mol Life Sci CMLS. 2015;72(19):3677–93.
Article CAS PubMed Google Scholar
Maljevic S, Lerche H. Potassium channels: a review of broadening therapeutic possibilities for neurological diseases. J Neurol. 2013;260(9):2201–11.
Article CAS PubMed Google Scholar
MacKinnon R. Potassium channels. FEBS Lett. 2003;555(1):62–5.
Article CAS PubMed Google Scholar
Christie MJ, North RA, Osborne PB, Douglass J, Adelman JP. Heteropolymeric potassium channels expressed in Xenopus oocytes from cloned subunits. Neuron. 1990;4(3):405–11.
Article CAS PubMed Google Scholar
Choe S, Kreusch A, Pfaffinger PJ. Towards the three-dimensional structure of voltage-gated potassium channels. Trends Biochem Sci. 1999;24(9):345–9.
Article CAS PubMed Google Scholar
González C, Baez-Nieto D, Valencia I, Oyarzún I, Rojas P, Naranjo D, et al. K(+) channels: function-structural overview. Compr Physiol. 2012;2(3):2087–149.
Sands Z, Grottesi A, Sansom MSP. Voltage-gated ion channels. Curr Biol CB. 2005;15(2):R44-47.
Article CAS PubMed Google Scholar
Hille B. Ionic selectivity of Na and K channels of nerve membranes. Membranes. 1975;3:255–323.
Hu JH, Malloy C, Tabor GT, Gutzmann JJ, Liu Y, Abebe D, et al. Activity-dependent isomerization of Kv4.2 by Pin1 regulates cognitive flexibility. Nat Commun. 2020;11(1):1567.
Article CAS PubMed PubMed Central Google Scholar
Hibino H, Inanobe A, Furutani K, Murakami S, Findlay I, Kurachi Y. Inwardly rectifying potassium channels: their structure, function, and physiological roles. Physiol Rev. 2010;90(1):291–366.
Article CAS PubMed Google Scholar
Li WP, Cui XD, Cheng M. Function and expression of inwardly rectifying potassium channel Kir2.1. Sheng Li Ke Xue Jin Zhan. 2015;46(4):287–9.
Mayfield J, Blednov YA, Harris RA. Behavioral and genetic evidence for girk channels in the CNS: role in physiology, pathophysiology, and drug addiction. Int Rev Neurobiol. 2015;123:279–313.
Article CAS PubMed PubMed Central Google Scholar
Wei AD, Gutman GA, Aldrich R, Chandy KG, Grissmer S, Wulff H. International union of pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels. Pharmacol Rev. 2005;57(4):463–72.
Article CAS PubMed Google Scholar
Weatherall KL, Goodchild SJ, Jane DE, Marrion NV. Small conductance calcium-activated potassium channels: from structure to function. Prog Neurobiol. 2010;91(3):242–55.
Article CAS PubMed Google Scholar
Kuiper EFE, Nelemans A, Luiten P, Nijholt I, Dolga A, Eisel U. K(Ca)2 and k(ca)3 channels in learning and memory processes, and neurodegeneration. Front Pharmacol. 2012;3:107.
Article PubMed PubMed Central Google Scholar
Berkefeld H, Fakler B, Schulte U. Ca2+-activated K+ channels: from protein complexes to function. Physiol Rev. 2010;90(4):1437–59.
Article CAS PubMed Google Scholar
Kim D. Physiology and pharmacology of two-pore domain potassium channels. Curr Pharm Des. 2005;11(21):2717–36.
留言 (0)